Charles Schwab Investment Management Inc Veracyte, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 762,097 shares of VCYT stock, worth $25.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
762,097
Previous 732,775
4.0%
Holding current value
$25.7 Million
Previous $16.2 Million
1.7%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding VCYT
# of Institutions
254Shares Held
82.1MCall Options Held
42.3KPut Options Held
18.2K-
Black Rock Inc. New York, NY7.79MShares$263 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.5MShares$253 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6.88MShares$232 Million0.03% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.81MShares$230 Million1.34% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.46MShares$117 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.42B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...